The dynamic changes in the carnitine pool under physiological and pathological conditions are extremely complex, and existing research may not yet have fully revealed the complete picture
Regulatory status will remain contingent on new data and prevailing evidence standards, as well as the absence of approved therapeutic uses to date
XL, JC, LL, XC, SS, and GC performed the research and wrote the first draft
Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD
Advances in transcriptomic analysis have enabled researchers to examine how small peptides interact with genetic regulatory networks
Its triple agonism allows simultaneous study of combined GLP-1 + GIP + glucagon effects, experimental dissections impossible with mono-agonists or dual agonists